ID

13683

Description

Maintenance Therapy: Lenalidomide Following Bendamustine and Rituximab Induction Therapy for Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01465230

Lien

https://clinicaltrials.gov/show/NCT01465230

Mots-clés

  1. 28/02/2016 28/02/2016 -
Téléchargé le

28 février 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Chronic Lymphocytic Leukemia NCT01465230

Eligibility Chronic Lymphocytic Leukemia NCT01465230

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
previous induction treatment with bendamustine and rituximab
Description

therapy induction ; bendamustine

Type de données

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0857127
UMLS CUI [2]
C0525079
18 or more years of age
Description

age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
chronic lymphocytic leukemia
Description

chronic lymphocytic leukemia

Type de données

boolean

Alias
UMLS CUI [1]
C0023434
ecog performance status less than or equal to 2
Description

ecog performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
absolute neutrophile count more than 1,000
Description

absolute neutrophil count

Type de données

boolean

Alias
UMLS CUI [1]
C0948762
platelet count more than 70,000
Description

platelet count

Type de données

boolean

Alias
UMLS CUI [1]
C0032181
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
serious medical condition that would prevent treatment with lenalidomide
Description

comorbidity affecting treatment

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0087111
evidence of tumor lysis syndrome
Description

tumor lysis syndrome

Type de données

boolean

Alias
UMLS CUI [1]
C0041364
any prior treatment with lenalidomide
Description

treatment lenalidomide

Type de données

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C1144149

Similar models

Eligibility Chronic Lymphocytic Leukemia NCT01465230

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
therapy induction ; bendamustine
Item
previous induction treatment with bendamustine and rituximab
boolean
C0087111 (UMLS CUI [1,1])
C0857127 (UMLS CUI [1,2])
C0525079 (UMLS CUI [2])
age
Item
18 or more years of age
boolean
C0001779 (UMLS CUI [1])
chronic lymphocytic leukemia
Item
chronic lymphocytic leukemia
boolean
C0023434 (UMLS CUI [1])
ecog performance status
Item
ecog performance status less than or equal to 2
boolean
C1520224 (UMLS CUI [1])
absolute neutrophil count
Item
absolute neutrophile count more than 1,000
boolean
C0948762 (UMLS CUI [1])
platelet count
Item
platelet count more than 70,000
boolean
C0032181 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
comorbidity affecting treatment
Item
serious medical condition that would prevent treatment with lenalidomide
boolean
C0009488 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
tumor lysis syndrome
Item
evidence of tumor lysis syndrome
boolean
C0041364 (UMLS CUI [1])
treatment lenalidomide
Item
any prior treatment with lenalidomide
boolean
C0087111 (UMLS CUI [1,1])
C1144149 (UMLS CUI [1,2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial